MoneyWorks4Me

The sales for the June 2022 quarter moved down to Rs. 3300.70 millions as compared to Rs. 4055.70 millions during the year-ago period.The Net Loss for the quarter ended June 2022 is Rs. -191.80 millions as compared to Net Profit of Rs. 505.60 millions of corresponding quarter ended June 2021A decline of 161.60 millions was observed in the OP in the quarter ended June 2022 from 976.60 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 3300.70 4055.70 -18.62 3300.70 4055.70 -18.62 12683.40 16168.80 -21.56
Other Income 64.80 58.00 11.72 64.80 58.00 11.72 187.60 284.10 -33.97
PBIDT 161.60 976.60 -83.45 161.60 976.60 -83.45 991.10 4137.40 -76.05
Interest 225.00 189.20 18.92 225.00 189.20 18.92 752.70 844.70 -10.89
PBDT -63.40 781.60 -108.11 -63.40 781.60 -108.11 203.50 3292.70 -93.82
Depreciation 280.50 276.00 1.63 280.50 276.00 1.63 1120.10 1083.10 3.42
PBT -343.90 505.60 -168.02 -343.90 505.60 -168.02 -916.60 2209.60 -141.48
TAX -152.10 0.00 0.00 -152.10 0.00 0.00 -331.00 0.00 0.00
Deferred Tax -152.10 -88.40 72.06 -152.10 -88.40 72.06 -331.00 -386.40 -14.34
PAT -191.80 505.60 -137.94 -191.80 505.60 -137.94 -585.60 2209.60 -126.50
Equity 360.00 359.20 0.22 360.00 359.20 0.22 360.00 359.30 0.19
PBIDTM(%) 4.90 24.08 -79.67 4.90 24.08 -79.67 7.81 25.59 -69.46
Peers
Company Name CMP
Sun Pharma. Inds. 1760.60
Dr. Reddys Labs. 1220.75
Cipla 1333.70
Lupin 1959.20
Zydus Lifesciences 1140.75
View more..